The role of the blood transcriptome in innate inflammation and stroke

Annals of the New York Academy of Sciences

Volumn 1207, Issue , 2010, Pages 41-45

  Freedman, Jane E ^a   Vitseva, Olga ^a   Tanriverdi, Kahraman ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood; Cerebral ischemia; Gene expression; Inflammation; Transcript

Indexed keywords

CALCIUM BINDING PROTEIN; DIPYRIDAMOLE; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; PROTEIN S 100; REACTIVE OXYGEN METABOLITE; TRANSCRIPTOME; UNTRANSLATED RNA;

ARTICLE; BRAIN INJURY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; DISEASE COURSE; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; INFLAMMATION; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; OXIDATIVE STRESS; STROKE; TISSUE INJURY; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; BLOOD; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; REVIEW; RISK FACTOR;

ANIMALS; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MODELS, NEUROLOGICAL; RISK FACTORS; STROKE;

EID: 78149238151     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05731.x     Document Type: Article

References (48)

1. Rosamond,W., K. Flegal, K. Furie, et al. 2008. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-e146.
2. Vinik, A. & M. Flemmer. 2002. Diabetes and macrovascular disease. J. Diabetes Complicat. 16: 235-245.
3. Williams, L.S., J. Rotich, R. Qi, et al. 2002. Effects of admission hyperglycemia onmortality and costs in acute ischemic stroke. Neurology 59: 67-71.
4. Duncan, B.B., M.I. Schmidt, J.S. Pankow, et al. 2003. Lowgrade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52: 1799-1805.
5. Cosentino, F. & G.E. Assenza. 2004. Diabetes and inflammation. Herz 29: 749-759.
6. Wang, C.X., T. Yang&A. Shuaib. 2001. An improved version of embolic model of brain ischemic injury in the rat. J. Neurosci. Meth. 109: 147-151.
7. Fagan, S.C., D.C. Hess, L.S. Machado, et al. 2005. Tactics for vascular protection after acute ischemic stroke. Pharmacotherapy 25: 387-395.
8. Maddahi, A. & L. Edvinsson. 2010. Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. J. Neuroinflammation 7: 14.
9. Yorek, M.A. 2003. The role of oxidative stress in diabetic vascular and neural disease. Free Radic. Res. 37: 471-480.
10. Kusaka, I., G. Kusaka, C. Zhou, et al. 2004. Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury. Am. J. Physiol. Heart Circ. Physiol. 286: H2442-H2451.
11. Mateos-Caceres,P.J., A. Garcia-Mendez, A. Lopez Farre, et al. 2004. Proteomic analysis of plasma from patients during an acute coronary syndrome. J. Am. Coll. Cardiol. 44: 1578-1583.
12. Hakonarson, H., S.F. Grant, J.P. Bradfield, et al. 2007. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 448: 591-594.
13. Wellcome Trust Case Control Consortium. 2007. Genomewide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
14. Kathiresan, S.,O.Melander, C.Guiducci, et al. 2008. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40: 189-197.
15. Freedman, J., M. Larson, K. Tanriverdi, et al. 2010. The relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham Heart Study. Circulation 122: 119-129.
16. Katoh,A.,H. Ikeda, T.Murohara, et al. 1998. Platelet-derived 12-hydroxyeicosatetraenoic acid plays an important role in mediating canine coronary thrombosis by regulating platelet glycoprotein IIb/IIIa activation. Circulation 98: 2891-2898.
17. Ross M.E., R. Mahfouz, M. Onciu, et al. 2004. Gene expression profiling of pediatric acute myelogenous leukemia. Blood 104: 3679-3687.
18. Greiner,T.C. 2004.mRNAmicroarray analysis in lymphoma and leukemia. Cancer Treat. Res. 121: 1-12.
19. Zent, C.S., F. Zhan, S.A. Schichman, et al. 2003. The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different antiapoptotic mechanisms but predict only some differences in phenotype. Leuk. Res. 27: 765-774.
20. Dhanasekaran, S.M., T.R. Barrette, D. Ghosh, et al. 2001. Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822-826.
21. Jison, M.L., P.J. Munson, J.J. Barb, et al. 2004. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 104: 270-280.
22. Huang, J., Z. Liang, B. Yang, et al. 2007. Derepression of microRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members. J. Biol. Chem. 282: 33632-33640.
23. Rana,T.M. 2007. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell. Biol. 8: 23-36.
24. Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
25. Ambros, V. & X. Chen. 2007. The regulation of genes and genomes by small RNAs. Development 134: 1635-1641.
26. Winter, J., S. Jung, S. Keller, et al. 2009. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell. Biol. 11: 228-234.
27. Suarez,Y.&W.C. Sessa. 2009.MicroRNAs as novel regulators of angiogenesis. Circ. Res. 104: 442-454.
28. Filipowicz, W., S.N. Bhattacharyya & N. Sonenberg. 2008. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight. Nat. Rev. Genet. 9: 102-114.
29. Griffiths-Jones, S., H.K. Saini, S. van Dongen & A.J. Enright. 2008. miRBase: tools for microRNA genomics. Nucleic Acids Res. 36: D154-D158.
30. Carmichael, S.T. 2003. Gene expression changes after focal stroke, traumatic brain and spinal cord injuries. Curr. Opin. Neurol. 16: 699-704.
31. Ford, G., Z. Xu, A. Gates, et al. 2006. Expression Analysis Systematic Explorer (EASE) analysis reveals differential gene expression in permanent and transient focal stroke rat models. Brain Res. 1071: 226-236.
32. Platts, A.E., C. Lalancette, B.R. Emery, et al. 2010. Disease progression and solid tumor survival: a transcriptome decoherence model. Mol. Cell. Probes 24: 53-60.
33. Ratan, R.R., A. Siddiq, L. Aminova, et al. 2008. Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury. Ann. N.Y. Acad. Sci. 1147: 383-394.
34. Zeller, T., P. Wild, S. Szymczak, et al. 2010. Genetics and beyond-the transcriptome of humanmonocytes and disease susceptibility. PLoS One 5: e10693.
35. Liu, D.Z., Y. Tian, B.P. Ander, et al. 2010. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab. 30: 92-101.
36. Xu, Z., G.D. Ford,D.R. Croslan, et al. 2005.Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression. Neurobiol. Dis. 19: 461-470.
37. Grond-Ginsbach, C., M.Hummel, T.Wiest, et al. 2008. Gene expression in human peripheral blood mononuclear cells upon acute ischemic stroke. J. Neurol. 255: 723-731.
38. Moore D.F., H. Li, N. Jeffries, et al. 2005. Using peripheral bloodmononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation 111: 212-221.
39. Tang, Y., H. Xu, X. Du, et al. 2006. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J. Cereb. Blood Flow Metab. 26: 1089-1102.
40. Tan, K.S., A. Armugam, S. Sepramaniam, et al. 2009. Expression profile of MicroRNAs in young stroke patients. PLoS One 4: e7689.
41. Liu, S.L., Y.H. Li, G.Y. Shi, et al. 2007. The effect of statin on the aortic gene expression profiling. Int. J. Cardiol. 114: 71-77.
42. Landrier, J.F., C. Thomas, J. Grober, et al. 2004. Statin induction of liver fatty acid-binding protein (l-FABP) gene expression is peroxisome proliferator-activated receptoralpha-dependent. J. Biol. Chem. 279: 45512-45518.
43. Chakrabarti, S., P. Blair, C.Wu&J.E. Freedman. 2007. Redox state of dipyridamole is a critical determinant for its beneficial antioxidant and antiinflammatory effects. J. Cardiovasc. Pharmacol. 50: 449-457.
44. Chakrabarti, S., O. Vitseva, D. Iyu, et al. 2005. The effect of dipyridamole on vascular cell-derived reactive oxygen species. J. Pharmacol. Exp. Ther. 315: 494-500.
45. Weyrich, A.S., M.M. Denis, J.R. Kuhlmann-Eyre, et al. 2005. Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates. Circulation 111: 633- 642.
46. Weyrich, A.S., L.W. Kraiss, S.M. Prescott & G.A. Zimmerman. 2006. New roles for an old drug: inhibition of gene expression by dipyridamole in platelet-leukocyte aggregates. Trends Cardiovasc. Med. 16: 75-80.
47. Xu, H., Y. Tang, D.Z. Liu, et al. 2008. Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke. J. Cereb. Blood Flow Metab. 28: 1320-1328.
48. Feezor, R.J., H.V. Baker, M. Mindrinos, et al. 2004. Whole blood and leukocyteRNA isolation for gene expression analyses. Physiol. Genomics 19: 247-254.